Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lannett Company, Inc. stock logo
LCI
Lannett
$1.54
$0.64
$3.72
$7.38M0.9592,067 shs280,600 shs
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
$3.14
+1.0%
$2.47
$1.61
$11.20
$199.13M0.86840,034 shs516,014 shs
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
$0.11
+1.7%
$0.13
$0.10
$0.26
$35.15M18,428 shs17,000 shs
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
$1.54
-1.9%
$1.48
$0.63
$1.91
$183.45M-0.05474,769 shs179,781 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lannett Company, Inc. stock logo
LCI
Lannett
0.00%0.00%0.00%0.00%0.00%
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
+0.96%+1.95%+30.29%+60.20%-58.85%
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
+1.68%-9.63%-11.90%-15.07%-57.15%
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
-1.91%-13.48%+8.45%+63.26%+86.67%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Lannett Company, Inc. stock logo
LCI
Lannett
N/AN/AN/AN/AN/AN/AN/AN/A
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
1.8882 of 5 stars
3.61.00.00.02.61.70.0
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
1.4618 of 5 stars
0.05.00.00.03.31.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Lannett Company, Inc. stock logo
LCI
Lannett
0.00
N/AN/AN/A
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
3.11
Buy$18.50489.17% Upside
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
0.00
N/AN/AN/A
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest TLSA, LCI, LRMR, and SEOVF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/24/2025
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
6/24/2025
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$17.00 ➝ $15.00
6/24/2025
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$26.00
(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Lannett Company, Inc. stock logo
LCI
Lannett
$340.58M0.00N/AN/A($23.34) per share0.00
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
N/AN/AN/AN/A$2.69 per shareN/A
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/AN/AN/AN/A($0.04) per shareN/A
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
N/AN/AN/AN/A$0.04 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Lannett Company, Inc. stock logo
LCI
Lannett
-$231.62M-$18.88N/AN/AN/A-62.40%N/A-13.39%N/A
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
-$80.60M-$1.49N/AN/AN/AN/A-52.48%-46.08%8/6/2025 (Estimated)
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
-$23.65M-$0.04N/AN/AN/AN/A-396.49%9/15/2025 (Estimated)
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
-$11.86MN/A0.00N/AN/AN/AN/A8/5/2025 (Estimated)

Latest TLSA, LCI, LRMR, and SEOVF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/13/2025Q2 2025
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/A-$0.01N/A-$0.01N/AN/A
4/30/2025Q1 2025
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
-$0.42-$0.46-$0.04-$0.46N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Lannett Company, Inc. stock logo
LCI
Lannett
N/AN/AN/AN/AN/A
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
N/AN/AN/AN/AN/A
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/AN/AN/AN/AN/A
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Lannett Company, Inc. stock logo
LCI
Lannett
N/A
2.23
1.39
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
N/A
7.48
7.48
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/A
0.12
0.12
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
N/A
1.02
1.02

Institutional Ownership

CompanyInstitutional Ownership
Lannett Company, Inc. stock logo
LCI
Lannett
40.28%
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
91.92%
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/A
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
N/A

Insider Ownership

CompanyInsider Ownership
Lannett Company, Inc. stock logo
LCI
Lannett
13.12%
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
4.50%
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/A
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
39.82%
CompanyEmployeesShares OutstandingFree FloatOptionable
Lannett Company, Inc. stock logo
LCI
Lannett
81010.77 million9.35 millionOptionable
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
3064.03 million61.15 millionOptionable
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/A328.49 millionN/ANot Optionable
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
8116.85 million70.32 millionOptionable

Recent News About These Companies

Why Tiziana Life Sciences Ltd (TLSA) is Surging in 2025

New MarketBeat Followers Over Time

Media Sentiment Over Time

Lannett stock logo

Lannett NYSE:LCI

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.

Larimar Therapeutics stock logo

Larimar Therapeutics NASDAQ:LRMR

$3.14 +0.03 (+0.96%)
Closing price 07/3/2025 02:54 PM Eastern
Extended Trading
$3.14 0.00 (0.00%)
As of 07/3/2025 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. Larimar Therapeutics, Inc. is based in Bala Cynwyd, Pennsylvania.

Sernova Biotherapeutics stock logo

Sernova Biotherapeutics OTCMKTS:SEOVF

$0.11 +0.00 (+1.68%)
As of 07/3/2025 10:00 AM Eastern

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

Tiziana Life Sciences stock logo

Tiziana Life Sciences NASDAQ:TLSA

$1.54 -0.03 (-1.91%)
As of 07/3/2025 03:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti- receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.Kingdom.